id,evidence_inference_prompt_id,pmcid,outcome,intervention,comparator,outcome_type,intervention_events,intervention_group_size,comparator_events,comparator_group_size,intervention_mean,intervention_standard_deviation,comparator_mean,comparator_standard_deviation,standardized_mean_difference,smd_sampling_variance,log_odds_ratio,lor_sampling_variance,log_risk_ratio,lrr_sampling_variance,notes,is_data_complete,tiktoken_with_attributes_xml_token_num,tiktoken_without_attributes_xml_token_num,split,tiktoken_without_attributes_markdown_token_num,chunk_num_tokens,output,is_chunked
130,4925,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H2 (haloperidol 2 mg),binary,11,49,10,50,,,,,,,0.1466,0.2422,0.1155,0.1505,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1499, 1088]","| 2x2 contingency table for the given trial article
| The 2x2 contingency table generated from YAML
| Outcome: the incidence of postoperative nausea and vomiting (PON
---
###Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 8
    group_size: 50
comparator:
    events: 
---
",True
548,8462,3263860,Diabetic ketoacidosis,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,2232,"[1547, 895]","<table>
<tbody>
<tr>
<td style=""font-family: Times New Roman, Times, serif"">&nbsp;</td>
<td style=""font-family: Times New Roman, Times, ser
---
###Answer: 13 68 29
###Answer: correct
---
",True
49,6989,3169777,adverse event profile - headache,macitentan doses of 100 mg,placebo,binary,1,6,3,14,,,,,,,-0.3102,1.6242,-0.2513,1.0952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: {
  	""rows"": [
		{
			""outcome"":""intervention"",
			""group_size"":""6"",
			""events"": [
			
---
###Answer: 600
---
###Answer: 4 4
###Answer: no
###Answer: yes
---
",True
568,8555,5541727,Treatment-related serious adverse events,Allogeneic mesenchymal precursor cells,Control,binary,0,11,0,6,,,,,,,-0.5705449,4.24080268,-0.5389965,3.77380952,,TRUE,6118,5345,TEST,4032,"[889, 1526, 1474, 323]","Treatment-related serious adverse events 6 4 In the MPC + HA group, there were 3 patients reporting 4 treatment-related serious adverse 6 1 In the HA alone group, there were no
---
### table wrap
::: caption
Two-by-two contingencies:
:::

 Allogeneic mesenchymal precursor cells treatment was associated with a higher rate of treatment-related serious adverse
---
treatment: Allogeneic mesenchymal precursor cells
---
###Answer: {
  ""intervention"" : {
    ""events"" : 6,
    ""group_size"" : 10
  },
  ""comparator"" : {
    ""events"" :
---
",True
622,11904,3493722,eradication rate of H. pylori in PP,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,81,72,81,,,,,,,-0.1193468,0.23908451,-0.0139862,0.00328204,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,1357,[],"Note: For more information on YAML format, please refer to https://www.cbioportal.org/about/sample_data.html. The ""Events"" and ""Group_size"" fields are available only for ""intervention",False
50,6989,3169777,adverse event profile - headache,macitentan doses of 300 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: In YAML format:
intervention:
    events: 2
    group_size: 56
comparator:
    events: 0
    group_size: 56
###
---
###Answer: 300 30 0 12 (x) 96,530

###Answer: yes
---
###Answer: 300 300 8 300
---
",True
633,12277,3936115,"Subjective improvement in observed symptoms based on a single closed-end question (yes or no answer): ""Did you observe adequate relief of diverticulosis related to abdominal pain or discomfort within the past 12 months?",Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,17,30,5,22,,,,,,,1.49203942,0.39457014,0.9136205,0.18003565,found in table 3,TRUE,2217,2016,TEST,1562,"[1539, 38]","
###Answer: 15 17
---
###Answer: 91 31
---
",True
123,7936,4486927,the end-of-treatment virologic response,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,83,94,75,93,,,,,,,0.5938,0.1718,0.0907,0.004,,TRUE,14472,7883,TEST,5770,"[1531, 1282, 840, 1366, 1357]","In the Intervention column:
The number of patients who achieved an end of treatment virologic response (Y)
The number of patients exposed to the intervention (X)
### Answer: 91 (Y) — 
---

""x"" because I couldn't find the number of patients in the two treatment arms (peginterferon plus ribavirin) who have sustained virologic response at the end of treatment. I am unable to determine
---
###Answer: yaml
---
###Answer: 23.75, 37.75
---
### Answer: 24 x 60 = 1440
---
",True
623,11905,3493722,side effects,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,19,85,32,84,,,,,,,-0.7597079,0.11826386,-0.5331314,0.06021211,found in results section,TRUE,1684,1549,TEST,1357,[],"###Answer: {
	""rows"": [
		{
			""events"": ""32"",
			""group_size"": ""169""
		},
		{
	",False
313,9840,4928400,Stone-free rate,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,22,22,16,20,,,,,,,2.5074,2.3273,0.2192,0.014,,TRUE,4037,2288,TEST,1670,[1472],"2x2 contingency table in YAML format for the given trial article.
intervention:
	events: 100
	group_size: 22
comparator:
	events: 80
---
",True
543,7795,3508963,Baseline characteristics - left kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,63,120,,,,,,,-0.1000835,0.06675021,-0.0487902,0.01587302,,TRUE,3561,2387,TEST,1552,"[1416, 194]","### Answer: yaml-output:
###Answer: no matching rows

###Answer: x
---
###Answer: 107
---
",True
373,220,1475568,Baseline beta-blockers intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,32,59,46,64,,,,,,,-0.7684,0.1456,-0.2816,0.0204,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 2x2 contingency table in YAML format:
intervention:
    events: 46
    group_size: 66
comparator:
    events: 111

---
###Answer: 2 rows (2 columns):
  - row 1: events: 0, group_size: 27;
  - row 2: events: 0, group_size: 59
---
",True
14,12634,2667135,early discontinuations,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,10,103,54,97,,,,,,,-2.4161,0.1523,-1.7277,0.0988,,TRUE,11722,8106,TEST,5529,"[767, 1358, 1313, 1148, 1526]","### Answer: 26 x 15 
###Answer: yes
---
2x2 contingency table in YAML format for the given trial article:
study_design: parallel
groups:
  - name: Intervention
    set: CoPAT
    size: 93

---
###Answer: 2 x 2 contingency table in yaml format:
table_style: |item_style:
- |font_family: Times New Roman,serif
  - item_style: |font
---

  
###Answer: 2 x 2 contingency table in YAML format for the given trial article 

###Answer: 2x2 table in YAML for ""intervention"", ""comparator"", and
---

intervention:
    events: 4
    group_size: 103
comparator:
    events: 6
    group_size: 54

---
",True
384,877,2974815,The percentage of patients with controlled blood pressure (<140/90 mmHg),"phone calls"" group","no phone calls"" group",binary,,108,,246,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical values are not available.,FALSE,13659,6016,TEST,4469,"[1538, 1184, 1400, 921]","
phone calls"" group: 74, 108
no phone calls"" group: 67, 246
### Answer: phone calls"" group: 74, 108
###
---
The YAML format should include the fields ""events"" and ""group_size"" for the ""intervention"" and ""comparators"" groups:
intervention:
  events: 66
  group_size: 1
---
### Answer: 19D9F; 19D9F
###Answer: no match
---
###Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 35
    group_size: 18
comparator:
    events:
---
",True
535,7793,3508963,Response to treatment,Intravenous lidocaine,Intravenous morphine,binary,108,120,84,120,,,,,,,1.34992672,0.13227513,0.25131443,0.00449735,,TRUE,3561,2387,TEST,1552,"[1416, 194]","
###Answer: table wraps
- Intervention: Intravenous lidocaine
Group 1: YES
Group 2: NO
- Comparator: Intravenous morphine
Group 1: NO

---
###Answer: 2x2 contingency table in YAML format for the (drug-treatment) intervention, (drug-comparator) comparator, and (outcome_label) outcome.
---
",True
256,10573,5711682,myocardial infarction (MI),Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,2966,"[1498, 1519, 267]","### Description: myocardial infarction (MI) occurred in 0 out of 38 patients in the Genoss DES™ group and in 3 out of 39 patients in the Promus Element™ group (p
---


###Answer: [Table 2](#)
---
###Answer: 2x2 contingency table in YAML format for the specified trial article:
###Answer: yaml|2x2_table 15962502
---
",True
375,219,1475568,Baseline systolic dysfunction,Follow-up and thorough education on self-care,Standard information about self-care,binary,23,59,28,64,,,,,,,-0.1967,0.1347,-0.1154,0.0466,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: yaml
---
### answer: 1 2 2 12

###Answer: yes
---
",True
491,6484,5419060,Sample rejection rate: CHC A,Phlebotomy training programme,Control,binary,79,10218,60,7557,,,,,,,-0.0267831,0.02955691,-0.0265733,0.0290947,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: 2x2 contingency table for intervention, comparator, and outcome: 2100777076677781.
---
###answer: 19x39=702
---

intervention:
    events: 7
    group_size: 498
comparator:
    events: 3
    group_size: 591
###Answer: yes
---
###Answer: | Event rate in intervention groupEvent rate in control groupComparator: Phlebotomy training programmeCHC APre-intervention: 10/300 = 3.33%Post-inter
---
",True
132,2452,4574984,level of postoperative pain,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,234,326,261,326,,,,,,,-0.4566,0.0344,-0.1092,0.002,,TRUE,12997,7944,TEST,5795,"[725, 1250, 1527, 986, 1482, 637]","###Answer: 45 x 450
---
### Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
  events: 226
  group_size: 326
comparator:
 
---
### Rationale: 10.1371/journal.pone.0137824.t003
###Answer: x.
---
###Answer: 230 [247, 2230] 187 [176, 490] 687 [537, 836], intervention,
---
###Answer: yaml
---
### Answer: 221, 234
---
",True
43,6985,3169777,unexpected adverse events,macitentan doses of 600 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","### Article:  ## Methods This double blind, placebo controlled study was performed in 7 groups of 8 healthy male subjects. Doses of 0.2, 1, 5, 25, 1
---
###Answer: 2 rows of data.
---
###Answer: 2x2 contingency table in YAML format for the following Intervention, Comparator, and Outcome:
intervention:
    events: NUMBER
    group_size: NUMBER
comparator
---
",True
304,3880,4357072,reduction in erythematous area,topical pimecrolimus cream 1%,triamcinolone acetonide oral paste 0.1%,binary,14,15,10,15,,,,,,,1.9459,1.3714,0.3365,0.0381,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"
### Answer: 46, 5770
###Answer: 0.93 (x)
###Answer: 0.93 (x)",False
476,5523,4144850,Open defecation - adult women,Total Sanitation Campaign,Control,binary,1116,1525,1264,1514,,,,,,,-0.6167847,0.00813218,-0.1317697,0.00037096,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: x
---
###Answer: Group_size: 930
Events: 930 
x 930 
x 765 
x 105 
x 45
---
###Answer: 16 x 48 = 864
---

###Answer:
###Answer: 196
Table 3. Summary of baseline characteristics of the two groups by study arm. N = 1,514

###Answer:
###
---
###Answer: 403 331 310 331
###Answer: no
---
###Answer: 

###Answer: 

###Answer: 

###Answer: 17058
###Answer: 

###Answer: open_defecation
---
###Answer: [yaml]
---

v 6 p9 bo repo1 f2 c an p7 or vit or.9 e7.7 s 5 6 s2 ms
7 co r x
8 o7 n pd v7

95
---
",True
587,11581,115849,patients discontinued due to lack of efficacy,etoricoxib 90 mg once daily,placebo,binary,44,353,90,357,,,,,,,-0.8617127,0.04081995,-0.7043523,0.0282044,found in fig 1,TRUE,6464,5362,TEST,4091,"[1494, 1297, 1459]","###Answer: 3x3 contingency table in YAML format:
intervention:
    events: x       # intention to treat
    group_size: 357
comparator:
    events: x
---
### Answer: 138, 91
---

intervention:
    events: 2
    group_size: 357
comparator:
    events: 1
    group_size: 353

###Answer: yes
---
",True
508,6486,5419060,Techinque related rejections: CHC B,Phlebotomy training programme,Control,binary,15,4114,8,3973,,,,,,,0.59537147,0.19216284,0.59373435,0.1911719,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: 0.79, 96
###Answer: 0.77, 93
###Answer: 0.11, 94
###Answer: 0.
---
###Answer: 525,60
###Answer: yes
---
###Answer: 2x2 contingency table in YAML format for the given trial article is:
---
###Answer: 4 4 4 4
---
",True
173,2791,5079604,The 2-year failure rate,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,13,33,12,15,,,,,,,-1.8171,0.5436,-0.7084,0.0633,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,4923,"[743, 1716, 1545, 744]","###Answer: [
	""events"" : [
		""x"",
		""x""
	],
	""group_size"" : [
		""x"",
		""x""
	
---
### Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 0
    group_size: 16
comparator:
    events: 
---

metformin 1,000 mg daily, sitagliptin 100 mg daily
The 2-year failure rate
×××
123
###Answer: YAML FORM
---

###Answer: {
""intervention"": {
""events"": ""26"",
""group_size"": ""349""
},
""comparator"": {
""events"": ""78"",
""group
---
",True
652,13099,5976307,The incidence rate of vital sign fluctuation (VSF),etomidate,propofol based on midazolam,binary,17,62,31,62,,,,,,,-0.9734491,0.14556188,-0.6007739,0.05882353,found in table 3,TRUE,2560,2044,TEST,1751,"[1539, 115]","The incidence rate of VSF: 50% (6/12) and 27.4% (9/33) in etomidate and propofol, respectively ( *P = *.0
---
###Answer: 6389
---
",True
48,6989,3169777,adverse event profile - headache,macitentan doses of 25 mg,placebo,binary,2,6,3,14,,,,,,,0.6061,1.1742,0.4418,0.5952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 2x2 contingency table in YAML format for the given trial article:
name: intervention
cells:
- row: NUMBER = 2
- event: NA
- count: NUM
---
###Answer: 2x2 contingency table in YAML format for the given trials.

###Answer: yes
---
###Answer: {
	""intervention"": 
		""2"": 5,
		""3"": 3,
		""4"": 4,
		""5"": 4,
	
---
",True
93,10166,4173437,Complications,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"
###Answer: events: 2, group_size: 2; events: 15, group_size: 1; intervention: yaml-contest-reference-type: 2x2-conting",False
131,2451,4574984,numbers overall complications,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,238,326,241,326,,,,,,,-0.0472,0.0315,-0.0125,0.0022,,TRUE,12997,7944,TEST,5795,"[725, 1250, 1527, 986, 1482, 637]","###Answer: 276 589
---
### Answer: 167 x 156
###Answer: yes
---

Intervention: 110 events, 110 group_size
Comparator: 144 events, 144 group_size
Overall complications: x
---
###Answer: ﻿""events"": 479, ""group_size"": 771}
---
###Rationale: The given trial article has two parts:
- prospective cohort study on day 30 after surgery
- retrospective cohort study on one year follow-up
For the 30 day mort
---
### Table: 2x2 contingency table in YAML format
			intervention:
				NUM: 103
				NUM: 77
				NUM
---
",True
152,13479,5055753,The percentages of patients in the calm,0.2 mg oral clonidine,2 mg oral midazolam,binary,14,40,7,40,,,,,,,0.9316,0.2831,0.6931,0.1643,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,2114,"[1408, 869]","Intervention, Comparator, Outcome
group_size: 80
group_size: 80
events: 35
comparator: 2
events: 17.5

###Answer:
---
0.2 mg oral clonidine, 2 mg oral midazolam
---
",True
370,218,1475568,Baseline diabetes,Follow-up and thorough education on self-care,Standard information about self-care,binary,35,59,33,64,,,,,,,0.3148,0.1328,0.1402,0.0263,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: tabular_result(""x"", ""x"", ""x"", ""x"", ""x"", ""x"", ""x"", ""x"", ""y"", ""y"", ""y"", ""y"", ""y"")
###
---
###Answer: 18 100 42 39
18 events for intervention.
100 group_size for intervention.
42 events for comparator.
39 group_size
---
",True
10,9682,2363753,Grade III/IV stomatitis,Amifostine,Control,binary,0,20,5,20,,,,,,,-2.6775,2.2951,-2.3979,2.0866,Only abstract is available. Full text in PDF only.,TRUE,887,780,TEST,725,[],###Answer: 50 10,False
537,7795,3508963,Baseline characteristics - hydronephrosis in left kidney,Intravenous lidocaine,Intravenous morphine,binary,52,120,52,120,,,,,,,0,0.0678733,0,0.02179487,,TRUE,3561,2387,TEST,1552,"[1416, 194]","###Answer: yaml
---
###Answer: yaml
---
",True
108,1884,4188762,withdrawal response of rocuronium,ketamine,normal saline,binary,9,30,26,30,,,,,,,-2.7191,0.4472,-1.0609,0.0829,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[1468],"###Answer: events: 64, group_size: 30, events: 26, group_size: 10, events: 9, group_size: 30, events: 0,
---
",True
297,5596,4355974,ER visits,BostonBreathes system,Control,binary,1,28,1,14,,,,,,,-0.7309,2.114,-0.6931,1.8929,found in table,TRUE,7450,5464,TEST,3820,"[1514, 1128, 1114]","{
  ""intervention"": {
    ""events"": 112,
    ""group_size"": 39
  },
  ""comparator"": {
    ""events"": 97,
    ""
---
###Answer: 2011844444311111114444442112233
---
Intervention: BostonBreathes system
Comparator: Control
Outcome: ER visits

###Answer: x
---
",True
121,7938,4486927,"The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype",peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,17,23,2,24,,,,,,,3.4393,0.7709,2.1826,0.4737,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,5770,"[1531, 1282, 840, 1366, 1357]","
###Answer: true
---
###Answer:
| Recurrence Event Type                  | Total No. of Events                 | Total No. of Subjects at Risk / Group 1 | Events Percentage                                    || Experimental Intervention Recurrence Events
---
###Answer: yaml
---
###Answer:
events:
   events: x
   group_size: 88
comparator:
   events: 65
   group_size: 84

---
### Answer: The SVR rates if the patients had IL-28B rs8099917 TT genotype, and GT/GG genotype were 26 (27.7%), and
---
",True
500,6489,5419060,Preanalytical errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,10,3973,,,,,,,0.14784821,0.18382945,0.14744724,0.18283856,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: 47 178
---
###Answer: table_inline {
  table {
    background-color: transparent;
    border: 0;
    border-collapse: collapse;
    caret-color: transparent;
    color: ;

---
2x2 contingency table in YAML format (for the given trial article):
table:
    rows: 2
    columns: 2
  - cell: 1, 1
  - value: 2
---
###Answer: 2x2 contingency table in YAML format for the given trial article
###Answer: 2x2 contingency table in YAML format for the given trial article:
!!explanation:
---
",True
547,8463,3263860,Serious skin reactions,Real-Time Continuous Glucose Monitoring,Control,binary,0,69,0,68,,,,,,,-0.014493,4.02898703,-0.0143887,3.97122153,Unclear group sizes. Used the group size for 26-week visit.,TRUE,3178,2587,TEST,2232,"[1547, 895]","###Rationale: Real-time continuous glucose monitor
ing (CGM) did not improve glycemic control over 26 weeks compared to usual care in children aged 4 to 9 years with type 1 di
---
### Answer: 3, 36
###Answer: yes
---
",True
155,13480,5055753,the percentages of patients in the heavily sedated,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,2114,"[1408, 869]","
###Answer: 251
---

Intervention: 0.2 mg oral clonidine
Comparator: 2 mg oral midazolam
Events for intervention:
	heavily sedated: 45

---
",True
391,951,3278655,"The proportion of ""at risk"" components at 5 years",The trabecular metal tibial monoblock component (TM),cemented component.,binary,0,27,2,18,,,,,,,-2.1203,2.497,-1.9972,2.3117,Used numerical values from 5-year follow up provided in abstract.,TRUE,5463,3510,TEST,2857,"[1471, 1508, 109]","###Answer: 0 0 0 0.004 0.004
###Answer: no
###Answer: yes
---

###Answer: 267 289
---
###Answer: group_size: 192
group_size: 1
---
",True
502,6489,5419060,Preanalytical errors: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","###Answer: 2x2 contingency table in YAML format for the given trial article.

###Answer: true
---
###Answer: 124 391 1328 341
###Answer: yes
---
###Answer: yaml
---
###Answer: yaml
---
",True
653,13100,5976307,the incidence rate of adverse events disturbing the procedure,etomidate,propofol based on midazolam,binary,16,62,5,62,,,,,,,1.37756068,0.30178299,1.16315081,0.23024194,found in table 3,TRUE,2560,2044,TEST,1751,"[1539, 115]","###Answer:

###Answer: 29 < x > 0
7 < x > 7

###Answer: no
---
###Answer: yaml
---
",True
299,5598,4355974,Knowledge,BostonBreathes system,Control,binary,9,12,3,8,,,,,,,1.6094,0.9778,0.6931,0.2361,"found in table,",TRUE,7450,5464,TEST,3820,"[1514, 1128, 1114]","
intervention:
    events: 29
    group_size: 30
comparator:
    events: 13
    group_size: 14

###Answer: 29 out
---
###Answer: 2
---
###Answer: 5 x 40 + 7 x 45 + 5 x 50 = 1320 + 280 + 350 = 1910
---
",True
15,12635,2667135,rate of clinical success at the test-of-cure visit,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,89,103,54,97,,,,,,,1.6218,0.1244,0.4396,0.0097,,TRUE,11722,8106,TEST,5529,"[767, 1358, 1313, 1148, 1526]","### Answer: {
""intervention"": {
""events"": 85,
""group_size"": 103
},
""comparator"": {
""events"": 55,
""group_size
---
###Answer: 2x2 contingency table in YAML format for the given trial article.
---
	
intervention:
    events: 45
    group_size: 50
comparator:
    events: 28
    group_size: 47

### Answer: ok
---

###Answer:

  CoPAT: 89 (n=103) 
  IPAT: 54 (n=97)
4 (3.9%) 18 (18
---

###Answer: group_size: 93, events: 101
---
",True
481,5521,4144850,Sanitation facility improvement,Total Sanitation Campaign,Control,binary,630,1522,342,1512,,,,,,,0.88220198,0.00648706,0.6043171,0.00319287,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: 382 373
---
###Answer: YAML
---
###Answer: sanitation-stool-2013-yamledexample.yaml
---
###Answer: 2x2 contingency table for the given trial article:
Intervention: Total Sanitation Campaign
Comparator: Control
Outcome 1: No. of sanitation facilities improved from baseline: x
---
###Answer: 280 x 404 = 114 248
---
###Answer: 2x2 contingency table in YAML Format
| Event	| Pts = number of people with the event under investigation
| Comparison	| Total
| Row titles
| Intervention	| Column
---
###Answer: 166 1266
---
2 a


7 (s 1-ind 07 co. D u cl. A dis91.5 r.3
n ho .3  d 
nt www5 c pd b
1 sc
---
",True
339,11079,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","
###Answer: x
---

###Answer: 1 x ""NUM"", 1 x ""NUM"", 0 x ""NUM""
---


###Answer: 4
---
###Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome should be ""2x2 table.yaml"".
---
",True
107,1884,4188762,withdrawal response of rocuronium,lidocaine,normal saline,binary,6,30,26,30,,,,,,,-3.2581,0.4968,-1.4663,0.1385,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[1468],"
###Answer: 2x2 contingency table in YAML format for the given article:
intervention:
    events: 6
    group_size: 30
comparator:
    events: 
---
",True
251,12426,5614421,severity of any neonatal respiratory disease,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,8,402,7,388,,,,,,,0.1,0.273,0.0981,0.2628,,TRUE,25930,11480,TEST,8549,"[1444, 1135, 2706, 782, 3362, 411]","
intervention:
    events: 42
    group_size: 49
comparator:
    events: 41
    group_size: 48
### Answer: 42/4
---

intervention:
    events: 55
    group_size: 550
comparator:
    events: 54
    group_size: 540

### Answer: yes
---
©
~dis
V     
S 5 ⁄ 
	S q

S *1 1 9 ft pd       	2  7  d D
D^s ss   v q
---
###Answer: 2x2 contingency table in YAML format for the given trial article is:
intervention:
    events: 53
    group_size: 156
comparator:
   
---
o-co a-site-dis-8-sl-2-p or4 b-co cv;5 te s-fi-8-f-dis.2 .--01129 T -
for-8
---
###Answer: 2
---
",True
45,6989,3169777,adverse event profile - headache,macitentan doses of 0.2 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","### Answer: 6,6
---
###Answer: yaml
---
###Answer:
Macitentan, Endothelin-1 Receptor Antagonist: Examines the pharmacokinetics, safety, and tolerability of single ascending doses of macitentan, a
---
",True
512,6553,4033571,Adverse effects,Extended-release oxcarbazepine 1200 mg,Control,binary,69,123,67,121,,,,,,,0.02941389,0.06645516,0.01302008,0.01302358,,TRUE,8206,5593,TEST,4514,"[1252, 1528, 995, 1435, 220]","###Answer: {
  ""intervention"": {
    ""adverse_event"": {
      ""count"": 10
      ""group_size"": 400
    }
  },
  ""com
---
###Rationale: 2 × 2 contingency table for the outcome ""adverse effects"" based on the values in the ITT population is shown below:

###Answer: true
---
###Answer: 91 x 94
---
### Answer: 67 x 73 = 4831

###Answer: OPTION A IS CORRECT.
---
###Answer: 205 x 254
---
",True
66,1643,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,14,23,4,19,,,,,,,1.7636,0.4992,1.0617,0.2253,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,1073,[],"
### Answer: [
""x"": ""990""
""x"": ""40""
]",False
166,616,5062234,intraoperative supplemental fentanyl,Transversus abdominis plane block with 0.375% ropivacaine,local anesthetic infiltration of the port site.,binary,8,21,16,21,,,,,,,-1.6487,0.4644,-0.6931,0.0923,,TRUE,1345,1148,TEST,971,[],"intervention:
    events: 8
    group_size: 22
comparator:
    events: 16
    group_size: 22

###Answer: yes",False
258,10574,5711682,stent thrombosis,Genoss drug-eluting stent (DES),Promus Element,binary,0,38,0,39,,,,,,,0.0256,4.0513,0.0253,3.9494,,TRUE,13148,4660,TEST,2966,"[1498, 1519, 267]","### Answer: 2<img src="" />Genoss DES™: 1<img src="" />stent thrombosis<img src="" />Promus Element™: 0<img src="" />stent throm
---
### Answer: 13
Intervention: Genoss DES
Comparator: Promus Element
Outcome: stent thrombosis

###Answer: no
Intervention, Comparator, and Outcome should all
---
###Answer: yaml
---
",True
492,6484,5419060,Sample rejection rate: CHC B,Phlebotomy training programme,Control,binary,48,4114,45,3973,,,,,,,0.0300092,0.04355608,0.02966421,0.04256078,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: 2x2 table in YAML format for the given trial article:
name: ""Intervention (phlebotomy training): Comparator (no phlebotomy training): Outcome (Sample rejection rate
---
###Answer: yaml
---

intervention:
    events: 1
    group_size: 25
comparator:
    events: NA
    group_size: 25

###Answer: true
---
###Answer: 2014-08-27 22:52:49 +0200
---
",True
257,10571,5711682,target lesion revascularization (TLR),Genoss drug-eluting stent (DES),Promus Element,binary,1,38,1,39,,,,,,,0.0267,2.0533,0.026,1.948,,TRUE,13148,4660,TEST,2966,"[1498, 1519, 267]","### Rationale: Target lesion revascularization (TLR) event occurred in 2 patients in the Genoss DES™ group and none in the Promus Element™ group. The rate of TLR was 5.3%
---
### Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    - events: 2
    - group_size: 26
comparator:
    -
---
###Answer: 3.0 36.0
---
",True
252,12427,5614421,other respiratory morbidities,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,,402,,388,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,25930,11480,TEST,8549,"[1444, 1135, 2706, 782, 3362, 411]","
###Answer: yaml
---
### Answer:

###Answer: 22 rows

###Answer: x 

###Answer: 4 rows

###Answer: 2 rows
---
t
for [] /s b or     


N
N
C.I S

Re -t  2 *2   1 t-

2 1  3 a 
T s a re
---
###Answer: events: 493 x, group_size: 976 x
---
v te-8 ua fu!lt r-e--p-d-sh-
7-ca p or-t te5 f-dis9/-p
near9.5-t-a 7
---
###Answer: 248 x 247
---
",True
494,6484,5419060,Sample rejection rate: CDC D,Phlebotomy training programme,Control,binary,7,630,8,589,,,,,,,-0.2033272,0.27118345,-0.200825,0.26457205,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: 26
###Answer: 4
---
###Answer: 630 48 2279 37 1.11 2665 78 2341 60 1.2
---

intervention:
    events: 2
    group_size: 2
comparator:
    events: 1
    group_size: 1
###Answer: yes
---
###Answer: The rejection rate, for all primary outcomes, at CDC D increased from 63/925 (6.79%) to 97/959 (10.22%),
---
",True
381,225,1475568,Cardiac-related hospitalization,Follow-up and thorough education on self-care,Standard information about self-care,binary,20,59,25,64,,,,,,,-0.2231,0.1413,-0.1418,0.0574,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","---
intervention:
    events: 33
    group_size: 67
comparator:
    events: 67
    group_size: 98
###Answer: no
---
###Answer: Intervention: 0.068235294117647; 48Comparator: 1.91234357894124;
---
",True
376,223,1475568,Baseline angiotensin II receptor blockers (ARBs) intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ACEI intake.,FALSE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 2x2 contingency table in YAML format for the given trial article Intervention, Comparator, and Outcome:
intervention:
    events: 54
    group_size: 5
---
###Answer: 36
###Answer: x
---
",True
46,6989,3169777,adverse event profile - headache,macitentan doses of 1 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 4 × 4 table
###Answer: x 4
###Answer: 0 0 3 0
---
###Answer: 6 6 6 6
---
###Answer: 6
###Answer: x
---
",True
265,2787,2430617,adverse events,30 µg YIC,placebo,binary,,,,,,,,,,,,,,,,TRUE,7987,4896,TEST,3773,"[1376, 1439, 1402]","30 µg YIC, 60 µg YIC, placebo: 11, 7, 5

###Answer: 30 µg YIC, 60 µg
---


intervention:
    events: 5
    group_size: 26
comparator:
    events: 0
    group_size: 52
###Answer: true
---
###Answer: yaml
---
",True
47,6989,3169777,adverse event profile - headache,macitentan doses of 5 mg,placebo,binary,0,6,3,14,,,,,,,-1.3754,2.5265,-1.1838,2.0762,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 18, 6
---
###Answer: 600 m YAML
---

2x2 contingency table for the outcome ""adverse event profile - headache"" and ""intervention"" and ""comparator"" in YAML format:
intervention:
    events: 6
    group_
---
",True
507,6486,5419060,Techinque related rejections: CHC A,Phlebotomy training programme,Control,binary,20,10218,20,7557,,,,,,,-0.3023674,0.10023074,-0.3016766,0.09976981,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","

###Answer: yes
---
###Answer: 99.647 52 29.353 60
---
###Answer: 2x2 contingency table in YAML format for the given trial article
---
###Answer: 55 742, 329 208
---
",True
380,215,1475568,Daily weight monitoring at the end of treatment,Follow-up and thorough education on self-care,Standard information about self-care,binary,47,59,19,64,,,,,,,2.2275,0.1795,0.9871,0.0413,Used percentage found in text to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: intervention:
    events: 61
    group_size: 254
comparator:
    events: 166
    group_size: 254
###Answer
---
###Answer: 2.22 Table Wrap for ""Intervention, Comparator, and Outcome""
###Answer: yes
---
",True
588,11581,115849,patients discontinued due to lack of efficacy,naproxen 500 mg twice daily,placebo,binary,19,181,90,357,,,,,,,-1.0557184,0.07366085,-0.8761319,0.05541671,found in fig 1,TRUE,6464,5362,TEST,4091,"[1494, 1297, 1459]","###Answer: naproxen 500 mg twice daily; placebo; number of patients discontinued due to lack of efficacy: 27; 64; 15 
group_size
---

intervention:
    events: 4
    group_size: 63
comparator:
    events: x
    group_size: 63
###Answer: true
---

intervention:
    events: 2
    group_size: 253
comparator:
    events: 2
    group_size: 357

###Answer: yes
---
",True
254,12428,5614421,side effects,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,134,394,118,382,,,,,,,0.1424,0.0236,0.0962,0.0108,,TRUE,25930,11480,TEST,8549,"[1444, 1135, 2706, 782, 3362, 411]","
###Answer: 787
---

intervention:
    events: 362
    group_size: 398	
comparator:
    events: 346
    group_size: 389
---
l PM
P	//D
↑  0     6 
a *1
Dis.1 3
T B;P
5 *1 x 1 pt b1 ( .8 
T
A 
---
###Answer: 1 x 45 + 1 x 41

###Answer: yes
---
96-s-l f7 ay
2-T ms-near ft,  (sl-sl for pa.6-co a o-mc o-6 g9-1-e or1 t/cv4-7
---
###Answer: x x
---
",True
473,5711,3343759,aphasia types,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data is in figure and group sizes are not available in abstract or results sections.,FALSE,3838,2633,TEST,2065,"[1482, 570]","
###Answer: aphasia types
###Answer: x
---
###Answer: events: {number: 34}
---
",True
270,2991,3214395,bronchospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 47",group 3 involved bispectral index (BIS) of 37,binary,1,60,0,30,,,,,,,0.4304,2.7163,0.4217,2.618,,TRUE,1201,996,TEST,880,[],"2x2 table for bronchospasm in order of outcome timepoint closest to the given study design
###Answer: noqa
Intervention: BIS 60, BIS 47, BIS 37
",False
85,13567,3687098,The incidence rates of malignancy,sitagliptin 100 mg/day,comparator agent,binary,6953,7726,6403,6885,,,,,,,-0.3899,0.0037,-0.0328,0,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[663, 1394, 783, 1518, 1502, 881, 1592, 345]","###Answer: 577 x 7847 = ?
---
### Answer: 2014-05-01T00:00:00Z
intervention:
    events: 6
    group_size: 5378
comparator:

---
###Answer: 142.8 and 151.1, 0.90 and 0.93
---
###Rationale: In this example, there are 2 columns for the intervention. The first one is named ""intervention"" and it says the incidence rate of malignancy. The second one is named ""outcome"" and
---
### Table:
| Cells | Cells | 1 | 1 | 0 | 1 | 1 |
| Cells | Cells | 1 | 1 | 0 | 1 | 1 |
---
###Answer: 340 out of 100 260 x 100
---
###Answer: ​
intervention:
    events: 1
    group_size: 95
comparator:
    events: 0
    group_size: 94

---
###Answer: 2143996645288
---
",True
475,5523,4144850,Open defecation - adult men,Total Sanitation Campaign,Control,binary,1138,1525,1273,1514,,,,,,,-0.5857317,0.00839764,-0.1193432,0.00034804,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: 327 x 789
###Answer: yes
---
### Answer:  2009; Gates Foundation; India; Oral Rehydration Therapy.
---
###Answer: 373, 56
---
###Answer: | event of intervention - NUMBER
###Answer: | event of comparator - NUMBER
---
###Answer: {""rows"":[[""194"",""41""]]}{""rows"":[[""50"",""79""]]}}
###Answer: yes
---
2x2 table of the given trial article 

###Answer: 
intervention: 
comparator: 
outcome: 
total number of individuals in the outcome outcome cells 
						
---
###Answer: table-1:
2016-09-01 10:48:52 - page #1455

###Answer: yes
---

T
do m_v content 7 co 8 b d-5/dis.5
s o38/a i, D		
dis-8 y cm9 a b g -
 u media0
---
",True
497,6488,5419060,Request-form errors: CDC C,Phlebotomy training programme,Control,binary,6,2279,3,2321,,,,,,,0.71275138,0.50087135,0.71140856,0.49913036,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","phlebotomy: 700, 2279
other: 130, 104
---
###Answer: ((984) / (630 + 984)) x 100 = 34.5 x 100 = 34.5%
---
intervention:
    events: 4
    group_size: 250
comparator:
    events: 2
    group_size: 250
###Answer: yes
---
###Answer:
""x"": ""0""
""x"": ""0""
""x"": ""0""
""x"": ""0""
""x"": ""0""
""x"": ""0""
""x"":
---
",True
154,13480,5055753,the percentages of patients in the agitated sedation scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,,40,,40,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3292,2470,TEST,2114,"[1408, 869]","###Answer: clonidine: 23, 58
midazolam: 3, 15
---
0.2 mg oral clonidine 22 7.5 7.5 0.2 mg oral midazolam 22 5.5 12.5 0.
---
",True
632,12276,3936115,the number of abdominal ultrasound examinations performed for suspected diverticulitis and subsequent number of diverticulitis diagnosed based on abdominal US,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,1,30,5,22,,,,,,,-2.1435204,1.29330629,-1.9195928,1.12121212,found in table 2,TRUE,2217,2016,TEST,1562,"[1539, 38]","
Intervention: 1, 5
Comparator: 2, 3

###Answer: yes
---
###Answer: .* Provide explanation
---
",True
16,12636,2667135,deaths,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,4,103,18,97,,,,,,,-1.7297,0.3283,-1.5641,0.2855,,TRUE,11722,8106,TEST,5529,"[767, 1358, 1313, 1148, 1526]","###Answer: 86
---
###Answer:

###Answer: true

###Answer: x
---
###Answer: 3 x 44 = 163
---

###Answer: 21.4 of 103 = 20.78 x 97/103 = 18.78 x 18.78/97 = 0
---
### article:  ::::table wrap
::: caption
Mortality rates associated with treatment of bacteraemia in the community setting
:::

Characteristic CoPAT (*n* = 103
---
",True
389,875,2974815,percentage of patients with controlled blood pressure,"phone calls"" group","no phone calls"" group",binary,86,108,175,246,,,,,,,0.4612,0.0769,0.1128,0.004,"Used 80% for ""phone calls"" group and 71% for ""no phone calls"" group.",TRUE,13659,6016,TEST,4469,"[1538, 1184, 1400, 921]","
outcome:
    events: ""80""
    group_size: ""108""
This is the total number of patients who have the outcome (controlled blood pressure) divided by the total number of patients who are
---
###Answer: 226253648= 74 66
---
###Answer: 200135, 136, 20134, 47, 11264, 48, 152, 37, 1
---
###Answer: {
  ""intervention"": {
    ""events"": ""x"",
    ""group_size"": 82
  },
  ""comparator"": {
    ""events"": ""x"",
   
---
",True
627,12232,3510731,Clicked on Results link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,247,6051,515,5892,,,,,,,-0.8111953,0.0063486,-0.7614066,0.00565535,found in table 1,TRUE,1665,1296,TEST,943,[],###Answer: yaml,False
128,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H2 (haloperidol 2 mg),H0 (saline),binary,10,50,21,50,,,,,,,-1.0635,0.2071,-0.7419,0.1076,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1499, 1088]","
###Answer: 4x4 contingency table in YAML format for the given trial article:
intervention:
    events: 27 x ""x""
    group_size: 50 x 5
---
###Answer: 50 50 21 67 0 50 50
---
",True
690,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),reminder card together with the appointment letter (IG2),binary,94,102,91,107,,,,,,,0.72558246,0.20912731,0.0802913,0.00247759,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1528, 1001, 1446, 1508, 868]","### Answer: 92, 107
---
133, 467
###Answer: yes
---
###Answer: 90 162
###Answer: 90 162
---
### table wrap indentation
### caption
Agreement between self reported and documented influenza vaccinations compared to vaccination certificates compared to vaccination physicians' documentation
### label
A.2
---
###Answer: 2 x 42 = 84
---
",True
539,7795,3508963,Baseline characteristics - did not have hydronephrosis,Intravenous lidocaine,Intravenous morphine,binary,11,120,15,120,,,,,,,-0.3475425,0.17627388,-0.3101549,0.14090909,,TRUE,3561,2387,TEST,1552,"[1416, 194]","### Description: This is the main class. Any of its subclasses may be present, but only one must be present.
###Answer: true
---
###Answer: 104 x 94 = 9936
---
",True
369,217,1475568,Baseline hypertension,Follow-up and thorough education on self-care,Standard information about self-care,binary,51,59,57,64,,,,,,,-0.2448,0.305,-0.0299,0.0046,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 2x2 contingency table in YAML format for the given trial article is as follows:
###Answer: true
---
###Answer: 2 rows:
outcome:
    events: NUMBER
    group_size: NUMBER
comparator:
    events: x
    group_size: x
###Answer: yes
---
",True
382,876,2974815,discontinued treatment,"phone calls"" group","no phone calls"" group",binary,4,108,30,246,,,,,,,-1.284,0.2976,-1.1917,0.27,Values from results section text.,TRUE,13659,6016,TEST,4469,"[1538, 1184, 1400, 921]","67 108
###Answer: OPTION A IS CORRECT.
---
###Answer: {
  ""intervention"": {
    ""group_size"": 133,
    ""events"": 26
  },
  ""comparator"": {
    ""group_size"": 
---
###Answer: 262 x 77 2024 x 37
###Answer: yes
---
###Answer: 2x2 table in YAML format
""phone_calls"": {
  ""events"": 4,
  ""group_size"": 25
},
""no_phone_calls"":
---
",True
624,11906,3493722,good compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,74,81,74,81,,,,,,,0,0.31274131,0,0.00233567,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"### Response_type: Event rate
### Answer: 83.5
### Answer: 88.9",False
510,6486,5419060,Techinque related rejections: CDC D,Phlebotomy training programme,Control,binary,2,630,4,589,,,,,,,-0.7640755,0.75330176,-0.7604408,0.74671491,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: events: 8, group_size: 2, 3, events: 7, group_size: 1
---
###Answer: 2x2 contingency table in YAML format for the given trial artlice; phlebotomy training programme as intervention, control as comparator, and rejection as outcome.
---
###Answer: 2x2 contingency table in YAML format for the given trial article is:
intervention:
  - events: 2
  - group_size: 2
comparator:
  -
---
###Answer: 2014-05-01, 0.38, 19, 0.32, 19 # rejection rate of blood transfusion due to technical errors in before
---
",True
499,6489,5419060,Preanalytical errors: CHC A,Phlebotomy training programme,Control,binary,27,10218,17,7557,,,,,,,0.16134073,0.09609132,0.16094694,0.09563037,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: tabulate response
---
###Answer: 18 x 6609 = 114225 
			18 x 6441 = 112293 
			x = 
---
###Answer: 6 x 589 = 3514 => 266 (25.02%) => 266
###Answer: no
---
###Answer: 2x2 contingency table in YAML format for the given trial article:
| Event    | Group Size | Event       | Group Size |
|:----- |:----- |:----- |
---
",True
264,2786,2430617,HBeAg sero-conversion rate,60 µg of immune complexes (YIC),placebo,binary,17,80,7,79,,,,,,,1.0208,0.2314,0.8747,0.1765,effects found in abstract and exact number in results table,TRUE,7987,4896,TEST,3773,"[1376, 1439, 1402]","As shown in the first column of [Table 2](#) , 17 of 78 patients receiving placebo achieved HBeAg seroconversion. In contrast, 11 patients achieved the primary endpoint among 30 µ
---

yamllang:
- HBeAg sero-conversion rate is 2.2 (0.5-3.6). p=0.09.
- 60 µg of immune complex
---


# HBeAg sero-conversion rate in ""intervention"" group = 19/66 = 28.2% 
# HBeAg sero-conversion rate in ""comparator""
---
",True
62,1642,3309311,differences in the HDD,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"
###Answer: 13 x 18",False
379,214,1475568,Hospitalization or death,Follow-up and thorough education on self-care,Standard information about self-care,binary,25,59,39,64,,,,,,,-0.7522,0.1351,-0.3633,0.0331,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 124, 125
---
###Answer:

###Answer: 214 rows
---
",True
305,3882,4357072,reappearance of erythematous areas after 2 months posttreatment,pimecrolimus,triamcinolone acetate,binary,1,15,5,15,,,,,,,-1.9459,1.3714,-1.6094,1.0667,significance found in abstract and numbers in results,TRUE,2097,1624,TEST,1385,[],"
###Rules:
- ""unavailable"" – ""N/A""; do not provide a number
- ""not applicable"" – do not touch this cell; just leave it blank",False
39,6985,3169777,unexpected adverse events,macitentan doses of 5 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","
###Answer: 5.0 6.0

###Answer: x.  x.

###Answer: x.  x.
---
###Answer: 300 [comparator: placebo, intervention: macitentan, outcome: adverse events, severity: mild or moderate]
---
###Answer: 6 x 6 = 36

###Answer: OPTION D IS CORRECT.
---
",True
338,11078,5655920,vomiting,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","
###Answer: 2869 1051 x
---
### Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome is:
intervention:
    events: 0
    group_size: 24

---
###Answer:

###Answer: 298 298

###Answer: 301 301
---
###Answer: yaml
---
",True
540,7795,3508963,Baseline characteristics - history of reurrent stone,Intravenous lidocaine,Intravenous morphine,binary,49,120,64,120,,,,,,,-0.504391,0.06797481,-0.2670628,0.0193665,,TRUE,3561,2387,TEST,1552,"[1416, 194]","###method:# Description:
In the present study, patients were also evaluated regarding having history of kidney stone, renal colic as (with a history of referring to the hospital or recurrent stone, and first referral first stone),
---
###Answer: 2.3.3 YAML
---
",True
358,8710,5971365,clinically meaningful improvement at week 144 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,188,287,144,277,,,,,,,0.5619,0.0299,0.2312,0.0052,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1474, 846]","
intervention:
    yaml: ! Map(1, [
      [2x2|""intervention""|clinically_meaningful_improvement at week 144 (3-point increase on
---

###Answer: {
      ""intervention"": [
        {
          ""numerator"": 72,
          ""group_size"": 79
        }
      ],
      ""comparator"": [

---
",True
109,1884,4188762,withdrawal response of rocuronium,remifentanil,normal saline,binary,0,30,26,30,,,,,,,-5.8839,2.2927,-3.9703,1.9732,Used percentage to calculate events as binary outcome.,TRUE,2068,1758,TEST,1564,[1468],"###Answer:
events: 37
group_size: 37
events: 26
group_size: 30
###Answer: yes
---
",True
341,11080,5655920,Nausea,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","###Answer: 23 167
---
### Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome is:
intervention:
    events: 2
    group_size: 2
com
---
###Answer: 2x2 contingency table in YAML format:
intervention:
    events: 33
    group_size: 514
comparator:
    events: 22

---
###Answer: yaml
---
",True
516,6554,4033571,Adverse effects,Extended-release oxcarbazepine 2400 mg,Control,binary,85,123,67,121,,,,,,,0.58935652,0.07152439,0.22156483,0.01029553,,TRUE,8206,5593,TEST,4514,"[1252, 1528, 995, 1435, 220]","###Answer: 37 x 17 ⇒ 613

###Answer: OPTION C IS CORRECT.
---
###Rationale: Treatment groups Event Total Events Percentage SPN-804 2400 mg 120 4.9 2 (1 - 4) 100 
---
###Answer: 244 89
---
###Answer: {
  ""intervention"": {
      ""events"": ""37"",
	""group_size"": ""19""
  },
  ""comparator"": {
      ""events"": ""10
---
###Answer: (34 x 85) (117 x 0) (117 x 28.7)
---
",True
133,2453,4574984,overall mortality,"intervention group, i.e. patient empowerment through information booklet and diary keeping","control group, which received standard care",binary,45,326,58,326,,,,,,,-0.3011,0.0468,-0.2538,0.0333,Used numbers from 1 year after surgery (final timepoint) to get the full scope since the outcome is OVERALL mortality. This info is found in Figure 6 caption.,TRUE,12997,7944,TEST,5795,"[725, 1250, 1527, 986, 1482, 637]","###Answer: 45 x 326 + 69 x 326 = 7671 + 7459 = 15130
---
### Answer: mortality rate: 18.13 (15.75; 20.66) 15.65 (12.53; 19.28) 0
---
2x2 contingency table:
intervention: 752, 75
comparator: 808, 80
Overall mortality: 808, 752


---
### Answer: 227 384 484 946 1247
###Answer: no
---

intervention:
  - events: 6
  - group_size: 245
comparator:
  - events: 4
  - group_size: 248
###Answer: 
---
###Answer: 10.1371/journal.pone.0137824.g008
###Answer: no

###Answer: yes
---
",True
138,3101,4830045,Birth status,Patients in the 3h group,Patients in the 20h group,binary,32,74,22,60,,,,,,,1 0.2746,0.1268,0.165,0.0465,Used numbers for live birth rate.,TRUE,2530,2096,TEST,1505,"[1540, 195]","
###Answer: true
###Answer: See above.
---
###Answer: 26 29
26 subjects out of 48 in the 3 h group had live birth while 20 subjects out of 31 in the 20 h group had live birth
---
",True
61,1642,3309311,differences in the disc herniation,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"
###Answer: acute severe LBP adults had disc herniation more frequently than mild LBP adults (chi-square = 9.226, p=0.003).",False
479,5526,4144850,Anemia,Total Sanitation Campaign,Control,binary,1078,1919,976,1922,,,,,,,0.21705107,0.00419838,0.10096226,0.00091084,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: 312 2736
---
*****

###Answer: 285 x 875
---
###Answer: 44 x 33 / 29 x 17 237
---
2x2 table: 2x2 contingency table in YAML format:
intervention: 1096
comparator: 1096
outcome: anemia: 187
1.
---
###Answer: {
  ""intervention"": {
    ""events"": ""1192"",
    ""group_size"": ""1830""
  },
  ""comparator"": {
    ""events
---
2x2 contingency table for the given trial article:

###Answer:
###Answer:
###Answer: yes
---
###Answer: 1694 1694
###Answer: 1694 1694
---
a iv
3 cr c 9 or_
tid i tv 1 b m.9 cm f7 b-9.
dis 1 q (6 or -
A 6 a d	581 dv a d
---
",True
337,11078,5655920,Nausea,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.1,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","
###Answer: 2094 [group_size: 2094]
[events: 14 [type: ""NUMERIC"", precision: 0, display_format: ""0"", unit:
---
### Table:
### Answer: 2x2 table in YAML format for the given intervention, comparator, and outcome.
Intervention: Lixisenatide
Comparator: Placebo
Outcome: Hyp
---

### Answer: lixisenatide-normal-renal-function:
    events: * ""x""
    group_size: 4692
lixisenatide-mild-renal-
---
### Answer: yaml
---
",True
194,2095,5360580,occurrence of adverse events,1 mg/day of Pls purified from scallop,placebo,binary,39,169,35,167,,,,,,,0.1235,0.0695,0.0963,0.0423,,TRUE,11096,9099,TEST,6033,"[1153, 513, 1313, 843, 1156, 1212]","###Answer: 3</p>
---
###Answer: 2 rows: for intervention & comparator
2 columns: for event & group_size

###Answer: yes
---
###Answer: 2x2 contingency table in YAML format for the given TrialArticle.
---
###Answer: 2x2 table for outcome ""adverse events""

###Answer: NO ANSWER
---
###Answer: events: 2; group_size: 12. events: 0; group_size: 31.
---

intervention:
    events: 6
    group_size: 285
comparator:
    events: 5
    group_size: 294
###Answer: true
---
",True
651,13098,5976307,The incidence rate of all cardiopulmonary adverse events,etomidate,propofol based on midazolam,binary,34,62,45,62,,,,,,,-0.7792931,0.1461718,-0.280302,0.01937592,found in table 3,TRUE,2560,2044,TEST,1751,"[1539, 115]","###Rationale: Treatment: 1 intervention, 62 propofol based on midazolam
Comparators: 1 intervention, 62 etomidate
Outcome: The incidence
---
###Answer: 2
---
",True
498,6488,5419060,Request-form errors: CDC D,Phlebotomy training programme,Control,binary,0,630,0,589,,,,,,,-0.0672384,4.0032824,-0.0671833,3.9967203,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: x
---
###Answer: 20 61 8 1

###Answer: yes
---
###Answer: yaml
---
###Answer: 29 x 60 = 1740
---
",True
42,6985,3169777,unexpected adverse events,macitentan doses of 300 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 6,6
---
###Answer:
""x"":
###Answer: 11.36156 x 33.75586
---
###Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 8
    group_size: 6
comparator:
    events: 1
---
",True
541,7795,3508963,Baseline characteristics - history of first stone,Intravenous lidocaine,Intravenous morphine,binary,70,120,56,120,,,,,,,0.47000363,0.06776786,0.22314355,0.01547619,,TRUE,3561,2387,TEST,1552,"[1416, 194]","### Answer:
intervention:
    events: 108
    group_size: 120
comparator:
    events: 120
    group_size: 120

---
###Answer: 2x2 table
---
",True
495,6488,5419060,Request-form errors: CHC A,Phlebotomy training programme,Control,binary,8,10218,11,7557,,,,,,,-0.6208037,0.21613955,-0.6201303,0.2156789,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","###Answer: table wrap
---
###Answer: table wrap 
caption 
Revision rates for blood transfusion requests before and after the phlebotomy training.
table 

###Answer: true 

###Answer: 42
---
###Answer: group_size: 2264
intervention: 51
events: 2
comparator: 3
yami: 2
---
###Answer: yaml
---
",True
493,6484,5419060,Sample rejection rate: CDC C,Phlebotomy training programme,Control,binary,37,2279,38,2321,,,,,,,-0.0085462,0.05422687,-0.0084069,0.05247318,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","###Answer: 2x2 contingency table in YAML format for the given article: 
intervention:
    events: 38
    group_size: 8
comparator:
    events: 
---
###Answer: 2x2 contingency table in YAML format for this trial article.
---
###Answer: 2x2 contingency table title: Sample rejection rate: CDC C
intervention:
    events: 1893
    group_size: 599
comparator:

---
###Answer: yaml
---
",True
378,221,1475568,Baseline angiotensin-converting enzyme (ACE) inhibitors intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,,59,,64,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear since the values for this are reported with ARB intake.,FALSE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    data:
        events: x
        group_size: 53
comparator:
   
---

###Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome: 
intervention:
	events: NA
	group_size: NA
comparator
---
",True
87,13569,3687098,The incidence of the composite endpoint of rash,sitagliptin 100 mg/day,comparator agent,binary,131,7726,76,6885,,,,,,,0.4352,0.0211,0.4292,0.0205,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[663, 1394, 783, 1518, 1502, 881, 1592, 345]","###Answer: 26 111
---
###Answer: 6 6
---
###Answer: 260 260
---

intervention:
    group_size: 1172
    events: 806
comparator:
    group_size: 1160
    events: 563
###Answer
---
### Answer: 452.5
Intervention: 196.5 196.5 14.0 14.0 12.5 12.5 80.
---
###Answer: group_size: 707
intervention: events: 37, group_size: 338
comparator: events: 18, group_size: 349
##
---
### Answer: 46: 14
---
###Answer: tabular_results:
  - intervention:
      numerical_results:
      - label: Total number of patients with the composite outcome in the sitagliptin group
      - value: 40

---
",True
340,11079,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","An empty YAML response indicates that the respective 2x2 contingency table could not be generated because the outcome data could not be extracted from the article.
###Answer: x
---
### Answer: 2017;39:527-536
type: Journal Article
DOI: 10.2337/db17-0890
PMID:
---

### Answer: 257 899
### Answer: 111 422

###Answer: yes
---
###Answer: yaml
---
",True
20,3246,2972614,Adverse effects,Laser therapy (Group I),Placebo laser therapy (Group II),binary,0,30,0,22,,,,,,,-0.3042,4.0772,-0.2985,3.9243,,TRUE,7041,2968,TEST,1931,"[857, 1224]","###Answer: 2 x column | 2 x 2 contingency table

###Answer: x column, y row, total
---
### Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome. 
Intervention :: 
    events: 2
    group_size: 2

---
",True
628,12233,3510731,Clicked on Protocol link,received the debriefing information in the body of an email with links to protocol and results pages;,received these links after clicking on an initial link in the body of the email to view the debriefing information on a website.,binary,202,6051,362,5892,,,,,,,-0.6394594,0.00806473,-0.6100046,0.00737794,found in table 1,TRUE,1665,1296,TEST,943,[],###Answer: 515 1427,False
361,8713,5971365,clinically meaningful worsening at week 96 (⩾3-point decrease on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,140,720,169,682,,,,,,,-0.311,0.0167,-0.2425,0.0102,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1474, 846]","###Answer: 199 776 202
###Answer: x
---

daclizumab_beta_vs_IFN_beta-1a_clinically_meaningful_worsening_at_week_96_3point_decrease_on_SDMT
---
",True
509,6486,5419060,Techinque related rejections: CDC C,Phlebotomy training programme,Control,binary,18,2279,15,2321,,,,,,,0.20202879,0.12309816,0.20058293,0.12135258,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","###Answer: 2x2 contingency table for intervention, comparator, and outcome categories in YAML format.

###Answer: yes
---
###Answer: yaml
---
###Answer: 2x2 contingency table in YAML format: (intervention, comparator, event, group_size)

###Answer: yes
---
###Answer: type: test,
tests: [
			strategy: count,
			data: [
				""intervention"",
				""control""
			],
---
",True
272,2991,3214395,extremity movement,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 49",group 3 involved bispectral index (BIS) of 39,binary,16,60,9,30,,,,,,,-0.1643,0.244,-0.1178,0.1236,,TRUE,1201,996,TEST,880,[],"### Description:
The sample size of the groups was the same (N=30 individuals) and all the subjects completed the study. The data for analysis was complete (no dropouts).
2x2 contingency table:
",False
137,1267,4709985,would have liked more information on acupuncture,tertiary education,other educations,binary,,121,,89,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Specific numbers were not given.,FALSE,3939,3288,TEST,2363,"[1341, 561]","### Article:  1

###Answer: [
  [""intervention"", {category: ""other educations"", response: ""x"" }],
  [""comparator"", {category: ""tertiary education"", response
---
###Answer: 132 44
---
",True
474,5522,4144850,Independent household latrines number,Total Sanitation Campaign,Control,binary,673,1525,366,1514,,,,,,,0.90730205,0.00626291,0.60187274,0.00290188,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: 2x2 contingency table in YAML format:
[
	""events"": 613,
	""group_size"": 451
},
[
	""events"": 
---
###Answer: outcome: Independent household latrines number
intervention: events: 1608
group_size: 1347
comparator: events: 1511
group_size: 
---
###Answer: 13, 39
---
###Answer: 2x2 contingency table of the given trial article
---
###Answer: yaml [""2x2 contingency table in YAML format for the following Intervention, Comparator, and Outcome: Intervention, Comparator, and Outcome: Intervention: Total Sanitation Campaign ,
---
2x2 table:
| Event | Group A | Group B |
|:-----:|:-----:|:-----:
|Intervention | -----:|:----:|:----:|----:
|Control
---
###Answer: 50 30
---

lt ra vit cr h-7 or ft pa 5 pa
9 u9 f5 eff
7 d2 b7 cm65-3 r -6 u  food pas 9 or b1 c bi 1
8
---
",True
477,5523,4144850,Open defecation - children,Total Sanitation Campaign,Control,binary,1279,1525,1350,1514,,,,,,,-0.4594912,0.0116852,-0.0612653,0.00020636,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: type: application/x-yaml
---
###Answer: 355, 2409
---
###Answer: 1. <p>intervention:</p> <table><thead><tr><th style=""width:30px;border-bottom:1px solid gray"">Events</th><th>Open Defec
---
###Answer: 2x2 contingency table in YAML format for the given trial article
---
###Answer: 40436:
	intervention:
		events: 40436
		group_size: 30016
	comparator:
		events:
---
###Answer: {
  ""title"": ""2x2 Contingency table for the Intervention, Comparator, and Outcome: Total Sanitation Campaign, Education, Enhanced Frequencies of the Outcome: Open Def
---
###Answer: 2x2 contingency table in YAML format for the given trial article:
---
3 or dis6 1 ra
6 v7 or i.
3 m PM9/nt l3 i 25 PM s! m i m
1 61 x q.
9 -
9
---
",True
315,9842,4928400,Complication,Transperitoneal laparoscopic ureterolithotomy,Flexible ureteroscopy,binary,5,22,7,20,,,,,,,-0.6047,0.4786,-0.4318,0.2474,,TRUE,4037,2288,TEST,1670,[1472],"
### Answer: 2x2 contingency table in YAML format for the given trial article:
# Treatment, N (%) 
Transperitoneal laparoscopic ureterolithot
---
",True
333,5080,5617873,Serious adverse effects,Aripiprazole,Placbeo,binary,0,47,1,45,,,,,,,-1.9681,2.3302,-1.9034,2.2431,all means and std found in table 2,TRUE,7551,5383,TEST,4396,"[1527, 693, 1517, 1010]","###Answer: 2.1.1
---


###Answer: 2036036
---

###Answer: 21
###Answer: 3
---
###Answer: 2x2 contingency table in YAML format for the trial article described: aripiprazole compared to placebo, for the outcome of serious adverse effects.

###Answer: 2x
---
",True
400,2243,4678179,rate of adverse events,vismodegib plus gemcitabine (GV),gemcitabine plus placebo (GP),binary,4,53,2,53,,,,,,,0.73315252,0.79001601,0.69314718,0.71226415,Used numbers found in results section text.,TRUE,9517,6474,TEST,5204,"[1511, 1514, 1341, 601]","###Answer:
intervention:
    events: 13 (3.01%)
    group_size: 430
comparator:
    events: 11 (1.95%)
   
---

###Answer: 20 [events] x 53 [group_size] / 53 [group_size] x 51 [group_size] = 20 / 2699 = 
---

intervention:
        events: 6
        group_size: 9
comparator:
        events: 1
        group_size: 9

###Answer: yes
---
###Answer: 2 rows:
– row[0]: value=""x"" group_size=""482"" events=""86""
– row[1]: value=""1"" group_size=""456"" events
---
",True
122,7936,4486927,The early virologic response (EVR),peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,86,94,82,93,,,,,,,0.3661,0.2397,0.0369,0.0024,,TRUE,14472,7883,TEST,5770,"[1531, 1282, 840, 1366, 1357]","EVR rate for 48 weeks(intervention): 91.5% (343/375)EVR rate for 24 weeks(comparator):88.2% (314/3
---
InterventionComparatorOutcomeEventsGroup_sizeEVR280395NA
---
###Answer: 2x2 contingency table for the given trial article:
| EVR || Peg-IFN + RBV for 48 weeks || Peg-IFN + RBV for 24
---
###Answer: 15 318, 2 318
---
### Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 260
    group_size: 48
comparator:
    events
---
",True
654,13101,5976307,The incidence rate of myoclonus,etomidate,propofol based on midazolam,binary,10,62,1,62,,,,,,,2.46221524,1.13562421,2.30258509,1.06774194,found in table 3,TRUE,2560,2044,TEST,1751,"[1539, 115]","
###Answer: events: 16
group_size: 62
intervention: MYOCLONUS
comparator: 8
group_size: 62
###Answer: false
---
###Answer: 20 x 360
---
",True
40,6985,3169777,unexpected adverse events,macitentan doses of 25 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: {
  ""intervention"": {
    ""events"": 3,
    ""group_size"": 6
  },
  ""comparator"": {
    ""events"": 0,
    ""
---
###Answer: 2x2 contingency table in YAML format:
intervention:
    events: 11
    group_size: 6
comparator:
    events: 2
    group_
---
###Answer: 32 is not a valid number.

###Answer: no answering groups found
---
",True
139,3100,4830045,Embryo quality,Patients in the 3h group,Patients in the 20h group,binary,,74,,60,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear outcome measures.,FALSE,2530,2096,TEST,1505,"[1540, 195]","
35 30
16 10
###Answer: yes
---
###Answer: 2x2 contingency table in YAML format for this query is:
---
",True
484,5713,3343759,history of myocardial infarction,very early speech and language therapy (SLT),control,binary,,,,,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Numerical data are only in methods section.,FALSE,3838,2633,TEST,2065,"[1482, 570]","
intervention:
    events: 71 90
    group_size: 31 32
comparator:
    events: 25 31
    group_size: 31 
---
###Answer:

Events:
  — “x” if cannot be determined
  — “0” if none
Comments:
  — Very early speech and language therapy (SLT) did not reduce the risk of
---
",True
496,6488,5419060,Request-form errors: CHC B,Phlebotomy training programme,Control,binary,12,4114,11,3973,,,,,,,0.05228567,0.17473861,0.05213706,0.17374765,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","
###Answer: table wrap style=""font-family: Times New Roman, Times, serif"">
    <tr>
      <td style=""font-size: 1.0476190476
---
###Answer: table wrap:
    caption: Request-form errors: CHC B
    colWidths:
        intervention: 80px
        comparator: 80px
        events: 8
---
Request-form errors: CHC B  Pre-intervention Post-intervention Total 4 (0.07) 9 (0.22) 13 3 (0.08) 10 (0
---
###Answer: yaml: 2x2_table_basic: |
							| intervention
							| comparator
							| outcome

---
",True
94,10167,4173437,Adverse effects,Tranexamic acid,Control,binary,0,30,0,30,,,,,,,0,4.0656,0,3.9355,Had to infer that the group sizes were equal.,TRUE,854,745,TEST,637,[],"
tranexamic_acid:
  - 0 events (0.0%), 6 patients (100.0%)
- group_size: 6
control:
  - NA, 0",False
482,5524,4144850,E. coli contaminated water,Total Sanitation Campaign,Control,binary,310,404,331,403,,,,,,,-0.3321747,0.03077414,-0.0680244,0.00129032,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: {
    ""intervention"": {
        ""events"": 237,
        ""group_size"": 304
    },
    ""comparator"": {
        ""events"": 1
---
### Answer: 872, 985
---
###Answer: 766, 399
---
###Answer: 2.1.2 Intervention: Numerator information only.
###Answer: 2.1.2 Intervention: 10.1001() 
###Answer: 2
---
###Answer: 0.0.664
---
###Answer: 33 x 33 x 22 x 32 = 17x {outcome}
###Answer: x {outcome}
---
###Answer: 30 536 x 188 513
---

d r-,
s j

 vit s-se iv e5 pa fu fi.6
5 d5  -4
ss a cm -7 t
3 mm. a 81 x5 D
---
",True
41,6985,3169777,unexpected adverse events,macitentan doses of 100 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 6 x 14 = 84
---
###Answer: 38 x 11; 10 x 10
---
###Answer: 600
---
",True
259,10575,5711682,rates of death,Genoss drug-eluting stent (DES),Promus Element,binary,1,38,0,39,,,,,,,1.1506,2.7186,1.1239,2.616,,TRUE,13148,4660,TEST,2966,"[1498, 1519, 267]","### Description: 2x2 contingency table in YAML format for the given trial article data.
###Answer: death rates are not different between the 2 stents at 9-month angiographic follow up.
---
###Answer: true
---
###Answer: yaml
---
",True
344,11082,5655920,Hypoglycaemia,Lixisenatide with moderate impairment,Lixisenatide with mild impairment,binary,,122,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = 0.04,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","###Answer: 1 14% higher incidence of GI AEs and a 10% higher incidence of nausea and vomiting were seen with mild impairment vs normal function ( P= .
---
### table wrap
:::caption
Contingency table and relative risk estimates for lixisenatide compared with placebo by renal function category (mITT population)
[*1]
:hasfootnotes:

---

---
###Answer: yaml
---
",True
362,8714,5971365,clinically meaningful improvement at week 96 (⩾3-point increase on the SDMT),daclizumab beta,intramuscular (IM) interferon (IFN) beta-1a,binary,432,720,369,682,,,,,,,0.2409,0.0117,0.1034,0.0022,"counts calculated from percentages given in text, totals found in figure",TRUE,3177,2394,TEST,2130,"[1474, 846]","
intervention:
    events: 129
    group_size: 919
comparator:
    events: 94
    group_size: 922

###Answer: yes
---

###Answer: 20 x 30
###Rationale: A total of 30 patients in the daclizumab beta group and 21 patients in the IM IFN beta-1a group
---
",True
65,1644,3309311,The proportion of HIZ incidence,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)",adults with LBP with radicular pain (group C),binary,14,23,3,18,,,,,,,2.0513,0.5825,1.2953,0.3057,Used percentage to calculate events as binary outcome.,TRUE,1437,1263,TEST,1073,[],"
### Answer: [2021-02-11 20:59:35,737+0800] 2.672431093722",False
377,222,1475568,Baseline digoxin intake,Follow-up and thorough education on self-care,Standard information about self-care,binary,15,59,12,64,,,,,,,0.3902,0.192,0.3045,0.1174,Used percentage found in table to calculate actual number for binary variable.,TRUE,4361,3649,TEST,2573,"[1460, 1155]","###Answer: 10 55 9
---
###Answer: 20 23
---
",True
626,11906,3493722,poor compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,2,81,3,81,,,,,,,-0.4182041,0.85881207,-0.4054651,0.80864198,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"###citation: Helicobacter pylori quadruple rescue therapy for treatment failures: 1- versus 2-week regimens. Author: Chang WK, Lee KK, Huang SP,",False
691,13831,4210722,use of a reminder card,a separate reminder card 4 days before the appointment (IG3); reminder card together with the appointment letter (IG2);,no further reminder (IG1),binary,185,209,84,104,,,,,,,0.60721747,0.10897683,0.09159567,0.00291009,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1528, 1001, 1446, 1508, 868]","###Answer: 391, 75
---
Intervention: 495; 423
Comparator: 484; 421
###Answer: yes
---
###Answer: 271,64

###Answer: OPTION A IS CORRECT.
---
###Answer: 3 31 25
---
###Answer: 0.022222222222222222 54954 1403
---
",True
342,11080,5655920,vomiting,Lixisenatide with moderate impairment,Lixisenatide with normal renal function,binary,,122,,2094,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.03,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","###Answer: 227 1476
---
### Table: [8048070-2019-660114-0000-0000024-AID2335552202
---

###Answer: 2x2 contingency table in YAML format for the given trial article:
outcome: vomiting
intervention:
    events: 39
    group_size: 60

---
###Answer: yaml
---
",True
625,11906,3493722,well compliance rates,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,8,81,4,81,,,,,,,0.74649316,0.40168564,0.69314718,0.35030864,"found in table 2, assumed binary because proportion of whole given",TRUE,1684,1549,TEST,1357,[],"###question:

###Answer: 60, 60",False
124,7937,4486927,The SVR rates when the patients had BMI >30 kg/m2,peginterferon (Peg-IFN) plus ribavirin (RBV) for 48 weeks,peginterferon (Peg-IFN) plus ribavirin (RBV) for 24 weeks,binary,10,19,6,12,,,,,,,0.1054,0.5444,0.0513,0.1307,"Even though the outcome says rate, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,14472,7883,TEST,5770,"[1531, 1282, 840, 1366, 1357]","The SVR rates when the patients had BMI >30kg/m2, using the ""intervention"" as the numerator and ""comparator"" as the denominator, are:
---
###Answer:
###Answer: true
###Answer:
###Answer:
###Answer:
intervention:
    events: 41
    group_size: 91
comparator:

---
###Answer: 2x2 contingency table in YAML format for the given trial article:
intervention:
    events: 66
    group_size: 94
comparator:
    events:
---
###Answer: yaml
---
### Answer: 2x2 contingency table for the given article
---
",True
546,8461,3263860,Severe hypoglycemia,Real-Time Continuous Glucose Monitoring,Control,binary,3,73,5,71,,,,,,,-0.5696661,0.56277056,-0.5386052,0.5055502,,TRUE,3178,2587,TEST,2232,"[1547, 895]","###Rationale: 
Intervention: Real-Time Continuous Glucose Monitoring
Comparator: Control
Outcome: Severe hypoglycemia

2x2 Contingency Table

##
---
###Answer: 0.3 x 49 + 0.0 x 15 = 4.8 + 0.0 = 4.8
---
",True
343,11081,5655920,Hypoglycaemia,Lixisenatide with normal renal function,Lixisenatide with mild impairment,binary,,2094,,637,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,placebo-adjusted meta-analysis (fixed effect) = -0.02,FALSE,13081,5825,TEST,4026,"[1471, 1525, 1439, 136]","
intervention:
    events: x
    group_size: 1310
comparator:
    events: x
    group_size: 867

###Answer: no adj. hypog
---
Placebo-adjusted odds ratio for hypoglycemia event with lixisenatide vs placebo by renal function category:
###Answer: no relevant information was found
---

###Answer: yaml
---
###Answer: yaml
---
",True
631,12275,3936115,The number of diverticulitis clinical symptom occurrences during 12months,Microencapsulated sodium butyrate (MSB) 300 mg daily,control group was administered placebo,binary,2,30,7,22,,,,,,,-1.8769173,0.7452381,-1.5629179,0.56406926,found in table 1,TRUE,2217,2016,TEST,1562,"[1539, 38]","
| Number of diverticulitis clinical symptom occurrences during 12 months of observation | 2 (6.67 %) | Number of abdominal ultrasound examinations performed for suspected di
---
###Answer: yaml
---
",True
127,4924,4493951,the incidence of postoperative nausea and vomiting (PONV),H1(haloperidol 1 mg),H0 (saline),binary,11,49,21,50,,,,,,,-0.9169,0.1993,-0.6264,0.0981,Used numbers from Late time (2–24 h),TRUE,3932,3205,TEST,2434,"[1499, 1088]","
### Answer: 2x2 contingency table in YAML format for the given trial article:
| | | | | 0 1 H1 H0 0 | | | | | 39 54
---
###Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome. Note: This question provides 4 answers: one with no rescue antiemetics used, one with rescue
---
",True
13,12633,2667135,proportion of patients completed therapy,some portion of therapy outside of the hospital (CoPAT),full course of therapy in the hospital setting,binary,93,103,44,97,,,,,,,2.4161,0.1523,0.6884,0.0135,,TRUE,11722,8106,TEST,5529,"[767, 1358, 1313, 1148, 1526]","###Answer: 20
---
###Answer: 2x2 contingency table in YAML format: 86, 23, 93, 44.
---
###Answer: YAML as input is not applicable
---

###Answer: outcome: COMPARATOR -> ""NUMERIC"" NUMBER, INTERVENTION -> ""NUMERIC"" NUMBER, COMPARATOR -> ""NUMERIC"" NUMBER, IN
---

###Answer: 2x2 contingency table in YAML format:
---
",True
269,2991,3214395,laryngospasm,"group 1 included bispectral index (BIS) of 60, group 2 covered bispectral index (BIS) of 46",group 3 involved bispectral index (BIS) of 36,binary,11,60,3,30,,,,,,,0.7033,0.4817,0.6061,0.3742,,TRUE,1201,996,TEST,880,[],"### Answers:
intervention: 36, 9
comparator: 12, 9

### Solution: The contingency table in YAML format:
""36"":
""9"":",False
478,5525,4144850,Helminth infections,Total Sanitation Campaign,Control,binary,34,581,32,569,,,,,,,0.04217391,0.06435212,0.0397543,0.05718313,Used percent to calculate outcomes for binary variables.,TRUE,24614,13328,TEST,9179,"[745, 1529, 544, 1840, 800, 1882, 411, 2798]","###Answer: yaml
---
###Answer: Helminth infections
---
###Answer: 269,187
---
###Answer:
###Answer: 
outcome: x
intervention: 
    events: 557
    group_size: 1241
comparator: 
    events: 5
---
###Answer:
---
###Answer: 4606
###Answer: x
---
###Answer: helminth: 1150, TOTAL {
  ""events"": ""66"",
  ""group_size"": 66,
  ""outcome"": true
}
###
---
s 2

S

8 w_v-2
2 da d8 or s3
2 u.--4 l61 m;

s d-v
v pd or45 A
7 u
---
",True
178,10755,5086025,Binge eating,Intuitive Eating and Acceptance and Commitment Therapy,Control,binary,7,26,14,26,,,,,,,-1.1527,0.3503,-0.6931,0.1374,,TRUE,29049,17627,TEST,13068,"[743, 1716, 1545, 1496, 585, 1509, 580, 1547, 1198, 3315]","###Answer: {
    ""intervention"" : {
	""events"" : ""33"",
	""group_size"" : ""18""
    },
    ""comparator"" : {
	""events
---
### Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome:
intervention:
    events: 16
    group_size: 8
com
---
### Answer: 11 x 16

###Answer: yes
---

###Answer: 2x2 contingency table in YAML format with the given data:
research_study:
	experiment_design: parallel
	groups:
		study_group:

---
###Answer: 27 x 21

###Answer: yes
---
2x2 contingency table Intervention Comparator Outcome events events group_size events group_size control 56 50 76 48 intuitive_eating 42 48 55 
---
### Answer: 6, 24
---
###Answer: 3, 24
---

###Answer: 2x2 contingency table for intuitive eating and binge eating (from Table 4 in the text of the trial article, with rows and columns labeled):
| 1 2 
---
c9 f_day98-1 p q47 c-b PM60 da te6 b n b s m h-7 c-near t a-f c5 pt p fi9 e0-dis3
---
",True
405,2807,5781260,adverse events,lemon verbena extract,placebo,binary,,20,,20,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Unclear numerical values.,FALSE,4385,3505,TEST,2662,"[813, 1505, 540]","###Answer: 17, 19
---
###Answer: Intervention:
					###Comment:
						""x""
						""x""
Comparator:
						""x
---
###Answer: 5, 18 (x)
---
",True
641,12879,5830087,objective response rate (ORR),"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,29,48,19,23,,,,,,,-1.1352878,0.38974592,-0.3128499,0.02280274,found in table 2,TRUE,11942,10628,TEST,8141,"[975, 1227, 1613, 1172, 594, 1847, 829, 982]","
###Answer: 60 x 61 = 379 x 2 vs 34 x 31 = 1089 x 2
---

###Answer: 20 677 1848

###Answer: 9, 8, 0, 1578, 677, 1848


---
###Answer: 11 : 322
---

results:
  or:
    trend:
      outcome: NUMERIC
###Answer: events: 26, group_size: 26
---
###Answer: 2.0.0

###Answer: yes
---
Outcome: NUMBER
---
26x6
26 rows x 6 columns
2 columns for intervention and comparator
6 columns for outcome (objective response rate, progressive disease, sisease, stable disease, complete response, partial response)
---
###Answer: 2x2 table in YAML | Contains outcome events

###Answer: x
---
",True
153,13479,5055753,The percentages of patients in the sedated scale,0.2 mg oral clonidine,2 mg oral midazolam,binary,17,40,7,40,,,,,,,1.2483,0.2755,0.8873,0.1517,"Even though the outcome says percentage, the way that the results are reported in the table makes it easier to calculate as binary outcome.",TRUE,3292,2470,TEST,2114,"[1408, 869]","
clonidine:
	events: 35
	group_size: 40
midazolam:
	events: 17.5
	group_size: 40
###
---
0.2 mg oral clonidine 40 20 2 mg oral midazolam 40 40
###Answer: option c IS CORRECT.
---
",True
542,7795,3508963,Baseline characteristics - right kidney stone,Intravenous lidocaine,Intravenous morphine,binary,60,120,57,120,,,,,,,0.10008346,0.06675021,0.05129329,0.01754386,,TRUE,3561,2387,TEST,1552,"[1416, 194]","### Answer: 7 23
7 rows and 2 columns:
- Number: 7   2x2 Contingency Table:
7: NUMBER  group_size: NUMBER   Intervention:
---
###Answer: 250
---
",True
689,13830,4210722,vaccination certificates were submitted,a separate reminder card 4 days before the appointment (IG3),no further reminder (IG1),binary,94,102,84,104,,,,,,,1.02876872,0.19754306,0.13189607,0.00312375,found in text as fractions of group sizes,TRUE,10493,8112,TEST,5695,"[1528, 1001, 1446, 1508, 868]","###Answer: 94, 91
---
102 204
---
###Answer: 303,2
---
### Answer: 197 165 2 x 197 165 2
###Answer: yes
---
### Answer: 29 35
###Answer: yes
---
",True
501,6489,5419060,Preanalytical errors: CDC C,Phlebotomy training programme,Control,binary,10,2279,15,2321,,,,,,,-0.3892899,0.16754104,-0.3872037,0.16579703,,TRUE,9292,5719,TEST,4155,"[1514, 525, 1525, 812]","### Answer: 1.43 1.68 1.36 1.47
---
###Answer: yaml
---
intervention events comparator events 1 pre 581 581 2 post 491 491 3 pre 512 512  4 post 472 47
---
###Answer: 139 x 137 468 83 x 185 452 139 x 452 649 137 x 46
---
",True
250,12425,5614421,The incidence of respiratory distress syndrome,vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,42,402,41,388,,,,,,,-0.0127,0.0539,-0.0113,0.0431,,TRUE,25930,11480,TEST,8549,"[1444, 1135, 2706, 782, 3362, 411]","
###Answer: 42 out of 402 = 10.44615384615384 of 402 for respiratory distress syndrome 10.
---
### Description:

###Answer: yes
---
## R q     6 q[         
O r4
2 4 
P (M 2 
a
F

9 7 ft  1 b 8 sv (↑ v (rm 
---
### Text elements: See original text for references and explanations

###Answer: yes
---
9-s 1.9-for-m-p5-co te-7-1 or-1 i-, t-12-o
19
p b.-57;n-o q-(7-5
---
###Answer: 179 x 394, 99 x 380
---
",True
174,2796,5079604,The probability of relapse,"metformin 1,000 mg daily, sitagliptin 100 mg daily",placebo,binary,9,33,11,15,,,,,,,-1.9924,0.4937,-0.9891,0.1051,Used percentage to calculate events as binary outcome.,TRUE,12690,6902,TEST,4923,"[743, 1716, 1545, 744]","###Answer: [
				""["",
				""["",
				""1"",
				""6"",
				""x"",
				
---
### Answer: 2x2 contingency table in YAML format:
intervention:
    events: 10
    group_size: 15
comparator:
    events: 15
   
---

intervention:
    events: 34
    group_size: 36
comparator:
    events: 77
    group_size: 39

###Answer: yes
---
###Answer: 2x2 contingency table in YAML format for the given Intervention, Comparator, and Outcome is :
intervention:
    events: 6
    group_size: 6
com
---
",True
64,1642,3309311,differences in the HIZ,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"
###Answer: yaml-result-table-wrap

###Answer: true",False
37,6985,3169777,unexpected adverse events,macitentan doses of 0.2 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: 3 x 16 x 6 x 16[9.882883381458881px=""18"" style=""font-family: Times New Roman,
---
###Answer: {
  ""intervention"": {
    ""events"": ""1"",
    ""group_size"": 6
  },
  ""comparator"": {
    ""events"": ""0"",
    ""
---
###Answer: 0.2 6 N/A N/A 1 N/A N/A 0.0081966 N/A 1.000000 5 N/
---
",True
38,6985,3169777,unexpected adverse events,macitentan doses of 1 mg,placebo,binary,0,6,0,14,,,,,,,0.8023,4.2228,0.7621,3.7905,One sentence that said no unexpected adverse events were found so values are all 0 based on this.,TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","### Answer: 6, 6
---
###Answer: 18 x 9 25 x 3
---
###Answer: 600 6 3
---
",True
467,4434,5726464,Metabolic syndrome,Vitamin D plus calcium supplementation,Placebo,binary,9,66,11,75,,,,,,,-0.0848389,0.23518906,-0.0728373,0.17353535,,TRUE,6563,4244,TEST,3133,"[637, 1214, 1538, 352]","###Answer: 207 <= events <= 214 37 <= group_size <= 37
---
###Answer: 69 69
---
###Answer: 13
---
###Answer: true
---
",True
621,11904,3493722,eradication rate of H. pylori in ITT,1-week quadruple rescue therapy,2-week quadruple rescue therapy,binary,71,85,72,84,,,,,,,-0.1681369,0.1827353,-0.0258207,0.00430393,"found in abstract and table, assumed binary because given as percentage of population",TRUE,1684,1549,TEST,1357,[],"### Rationale: In the ITT analysis, patients without final *^13^C urea breath test results or rapid urea test results were classified as treatment failures; good compliance was defined as taking more than 8",False
63,1642,3309311,differences in the annulus tear,"adults with acute axial severe LBP who could not sit up or stand up for several days, but had not experienced previous back-related diseases or trauma (group A)","adults who had been involved in a minor traffic accident, and had mild symptoms but not limited mobility (group B)",binary,,23,,19,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,Data is in graphic table.,FALSE,1437,1263,TEST,1073,[],"
###Answer:
###Answer: true",False
538,7795,3508963,Baseline characteristics - hydronephrosis in right kidney,Intravenous lidocaine,Intravenous morphine,binary,57,120,53,120,,,,,,,0.13431725,0.06721017,0.07275935,0.01974512,,TRUE,3561,2387,TEST,1552,"[1416, 194]","### Answer: 76 6	7	7 61	1 7	1 6 3
###Answer: no
---
###Answer: 292
---
",True
84,13566,3687098,adverse event of constipation,sitagliptin 100 mg/day,comparator agent,binary,178,7726,124,6885,,,,,,,0.2514,0.014,0.2463,0.0134,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[663, 1394, 783, 1518, 1502, 881, 1592, 345]","###Answer: 208 x 24014 14163
---
###Answer: 4 x 1
###Answer: yes
---
###Answer: 2018-06-06T19:09:29.479070+00:00 Intervention:
  - Total users: 384
---
###Rationale:
###Answer: 268 x 785 and 4 x 283
---
### Footnote: For clinical events, use the term ""event"" for the ""Outcome"". For laboratory events, use the term ""laboratory"" for the ""Outcome"". Note that we try to find a value for
---
###Answer: 0.42 (241 events in intervention group / 572 group_size = 241,572)
###Answer: OPTION C IS CORRECT.
---
###Answer: (only produce yaml response)
---
###Answer: {
    ""intervention"": {
        ""events"": 94,
        ""group_size"": 235
    },
    ""comparator"": {
        ""events"": 12
---
",True
118,2984,4323894,Rate of complications,Mild-cooling or deep-cooling,No cooling,binary,,10,,13,,,,,,,cannot calculate,cannot calculate,cannot calculate,cannot calculate,,FALSE,3049,2670,TEST,2328,"[1533, 1084]","
mild cooling: 9, 10
deep cooling: 4, 6
no cooling: 2, 3

###Answer: yes
---
###Answer: {
    ""intervention"": {
        ""events"": ""15"",
        ""group_size"": ""16""
    },
    ""comparator"": {
        ""events"": ""12
---
",True
182,4340,5122613,Adverse events,Digestion-resistant maltodextrin,Placebo,binary,0,33,0,33,,,,,,,0,4.0597,0,3.9412,Based on abstract.,TRUE,6184,3742,TEST,2832,"[1076, 1495, 194]","### Answer: {
label: ""Adverse events"",
data: [
  {
    events: ""x"",
    group_size: ""x""
  }
]
}
###Answer: noqa
---

###Answer: The given trial article, the Digestion-resistant Maltodextrin Capsule Supplement demonstrates safety and efficacy in ameliorating the symptoms and health-related quality of life in patients with
---
###Answer: 2 x 2 contingency table:
---
",True
253,12427,5614421,"adverse infant outcomes, including serious infant composite outcome",vaginal progesterone pessaries (equivalent to 100 mg vaginal progesterone),placebo,binary,155,406,152,393,,,,,,,-0.0211,0.0212,-0.013,0.008,,TRUE,25930,11480,TEST,8549,"[1444, 1135, 2706, 782, 3362, 411]","
###Answer: events: 101
    group_size: 200
intervention:
    events: 98
    group_size: 200
comparator:
    events:
---

intervention:
	Outcome: NUMBER
group_size: NUMBER
	Composite outcome: NUMBER
	Serious composite outcome: NUMBER
Comparator:
	Outcome: NUMBER
	Com
---

	3     ÿ 1 3 i
T	4 b6/,  2 0* 
P    1  
A
T b
3 a 9 u	v  t  5 n

---
###Answer: {
  ""intervention"": {
    ""events"": ""12"",
    ""group_size"": ""406""
  },
  ""comparator"": {
    ""events"": ""1
---
m-t u-7 be-s -5-
m PM;8-cl p-co o-7-til cl-34 m4-c c-s-5 [5-5-11 ft3 (
---
###Answer: 265 300
---
",True
266,2787,2430617,adverse events,60 µg of YIC,placebo,binary,7,163,4,79,,,,,,,-0.1728,0.4126,-0.1647,0.3741,effects found in abstract and number of samples in text,TRUE,7987,4896,TEST,3773,"[1376, 1439, 1402]","31, 6

###Answer: yes
---

intervention:
  - events: 327
  - group_size: 51
comparator:
  - events: 230
  - group_size: 50
###Answer
---
###Answer: 2.0.0 <-- NUMBER
###Answer: 40 <-- NUMBER
---
",True
36,6988,3169777,adverse event profile - headache,macitentan dose of 600 mg,placebo,binary,5,6,3,14,,,,,,,2.9087,1.6242,1.3581,0.2952,"Original outcome was ""adverse events profile"". Added ""headeache"" since that is the first adverse events reported.",TRUE,5143,4376,TEST,3326,"[1338, 1009, 1338]","###Answer: yaml file
---
###Answer: yaml
---
###Answer: 600 mg of macitentan caused an adverse event profile with 27 events and 6 subjects (6x6) having such profile, and placebo did not cause any adverse event profile
---
",True
86,13568,3687098,The incidence rates of pancreatitis,sitagliptin 100 mg/day,comparator agent,binary,773,7726,689,6885,,,,,,,-0.0002,0.0031,-0.0002,0.0025,Used incidence rate per 100 to get the binary events.,TRUE,15196,10904,TEST,8432,"[663, 1394, 783, 1518, 1502, 881, 1592, 345]","###Answer: 2680 (64) x 419 (6)
###Answer: no
---
###Answer: table:
    cells:
        - value: ""x""
        - style: ""table-cell""
    row:
        - value: [
            ""intervention"",
            ""104
---
###Answer: 4x4 contingency table
intervention:
    events: 14309
    group_size: 36440
    rate: 0.38 per 1
---
###Answer: 1 x 4

###Answer: no
---
### Answer: 4.55 x 171 = 7.89 x 10^4
---
###Answer: 311 59353
---
### Answer: 2x2 contingency table in YAML format for the given Intervention and Outcome.
intervention:
    events: 26
    group_size: 4416
comparator
---
###Answer: 24.055390684211024, 4904437563461
---
",True
642,12880,5830087,disease control rate,"BTH1677 arm ( intravenous [IV] BTH1677, 4 mg/kg, weekly; IV bevacizumab, 15 mg/kg, once each 3-week cycle [Q3W]; IV carboplatin, 6 mg/mL/min Calvert formula area-under-the-curve, Q3W; and IV paclitaxel, 200 mg/m2, Q3W)",Control arm ( bevacizumab/carboplatin/paclitaxel as above),binary,45,48,21,23,,,,,,,0.35667494,0.9031746,0.02643326,0.00552968,found in table 2,TRUE,11942,10628,TEST,8141,"[975, 1227, 1613, 1172, 594, 1847, 829, 982]","
###Answer: <snip>
---

###Answer: {
""intervention"": {
""rows"": [
{
""even"": 1,
""cells"": [
{
""event"": 16,
""group_size"": 1
---
BTH1677 arm (60 [44.85, 74.19] 64 [44.85, 74.19])
Control arm (21 [12
---

disease control rate:
    intervention: NUMERIC_POINT(""94.4%"")
    group_size: NUMERIC_POINT(""94"")
comparator: NUM
---
###Answer: 2x2 contingency table in YAML format for the Intervention, Comparator, and Outcome
---
Outcome, choose the group_id of the event of interest or the event to calculate. Choose the outcome of the group_id of the event of interest of the group_id of the event of the calculation of the outcome
---
###Answer: 367739468738
---
###Answer: {
""events"": {
""control"": {
""event_count"": 76,
""group_size"": 133
},
""experimental"": {
""event_count"": 
---
",True
